SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-06-028988
Filing Date
2006-02-13
Accepted
2006-02-13 16:47:38
Documents
4
Group Members
A. GRANT HEIDRICH, IIIF. GIBSON MYERS, JR.KEVIN A. FONGMAYFIELD ASSOCIATES FUND III, L.P.MAYFIELD IX MANAGEMENT, L.L.C.MAYFIELD VIII MANAGEMENT, L.L.C.WENDELL G. VAN AUKEN, IIIWILLIAM D. UNGERYOGEN K. DALAL

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G dsc13g.htm SC 13G 157858
2 JOINT FILING AGREEMENT dex991.htm EX-99.1 10570
3 RESOLUTION OF SIGNATURE AUTHORITY FOR JAMES T. BECK dex992.htm EX-99.2 81204
4 OWNERSHIP SUMMARY dex993.htm EX-99.3 16634
  Complete submission text file 0001193125-06-028988.txt   268493
Mailing Address 2800 SAND HILL ROAD SUITE 250 MENLO PARK CA 94025
Business Address 2800 SAND HILL RD SUITE 250 MENLO PARK CA 94025 8508545560
MAYFIELD IX (Filed by) CIK: 0001041602 (see all company filings)

Type: SC 13G

Mailing Address 341 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 341 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Subject) CIK: 0001061027 (see all company filings)

IRS No.: 943295878
Type: SC 13G | Act: 34 | File No.: 005-81034 | Film No.: 06604287
SIC: 2834 Pharmaceutical Preparations